Stay updated on Pimavanserin Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.

Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the history and an outdated funding notice was removed; these are minor site maintenance updates that do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center operating status was added. The revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check28 days agoChange DetectedUI changes include a glossary toggle and color-coded marks for additions and deletions, with the revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check35 days agoChange DetectedThe update adds revision v3.3.4 and removes v3.3.3, affecting only version metadata. No study data, eligibility criteria, results, or records are changed; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry (Revision: v3.3.3) was added to the record history; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedAdded a new revision entry (v3.3.2) in the study record history, replacing the previous version (v3.3.1).SummaryDifference0.1%

Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.